Humana AB/Skr HUM

1D1W1MYTD1Y5YMAX

About Humana AB

Ticker
Skr HUM
Sector
Health
Primary listing
XSTO
Employees
16,764
Headquarters
Stockholm, Sweden
Website
www.humanagroup.se

Humana AB Metrics

BasicAdvanced
kr 3.4B
19.83
kr 3.61
0.05
kr 1.35
1.89%

Bulls say / Bears say

Ambea’s recommended offer values Humana at SEK 62.30 per share before any litigation-related CVR, a 26.8% premium to the pre-offer price. Competition and foreign-investment approvals have now been cleared, while the acceptance period ends on 30 September 2026. (Reuters, Ambea)
The turnaround is beginning to show in the underlying numbers: second-quarter adjusted operating profit rose 6% year on year to SEK 81m, while Sweden’s Individual & Family margin improved from 6.1% to 7.2%. Free cash flow also more than doubled to SEK 229m. (Humana, Humana)
Humana has a sizeable route to future growth, with about SEK 550m of annual revenue in its current pipeline and roughly SEK 200m of new contracts signed year to date. Its net debt ratio fell to 2.4 times, and a refinancing is expected to cut annual net interest costs by about SEK 35m. (Exa, Inderes)
Growth remains weak on an underlying basis: second-quarter revenue rose 3%, but organic growth was negative 0.3%. First-half net profit fell to SEK 29m from SEK 91m, showing that the reported improvement in adjusted profit has not yet translated into stronger statutory earnings. (Humana)
Several operations still face direct margin or demand pressure. Finland’s Open Care revenue fell 22% year on year as municipalities cut services or brought them in-house, while Norway’s higher personnel costs were not fully covered by price increases and Swedish personal assistance margins were squeezed by low reimbursement growth. (Humana, Exa)
The legal upside attached to the takeover is uncertain: Stockholm District Court dismissed Humana Assistans’s damages claim against the state over the revoked permit, and Humana has appealed. The offer’s contingent value right depends on eventually winning that appeal, so investors should not treat it as guaranteed value. (Humana, Humana)
Data summarised monthly by Lightyear AI. Last updated on 28 Sept 2026.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.